What if I told you it is possible to increase 6⃣ times the detection of cardioaortic thrombi in stroke patients with a simple tweak to your current workflow?.🤯🤯🤯.We would only need to screen 1⃣4⃣ patients to find 1⃣ thrombus! Curious? Read on! DAYLIGHT Trial.

RT @J_Rosales_MD: 🧠🩸 Survey of 580 clinicians in LATAM.countries: .👉🏻only 28% have an ICH code 🏥📋.👉🏻INTERACT3 care bundle adherence ranges….

Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.

RT @ShadiYaghi2: Meet us at #WSC25 in Barcelona in October & attend a terrific program of cutting edge research. Also find out the final re….

RT @MicheleRomoli: Atrial fibrillation patients can still suffer a stoke while on DOACs. 𝐒𝐡𝐨𝐮𝐥𝐝 𝐰𝐞 𝐬𝐰𝐢𝐭𝐜𝐡 𝐭𝐨 VKA, 𝐭𝐫𝐲 𝐚 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐃𝐎𝐀𝐂, 𝐨𝐫….

RT @MicheleRomoli: Kudos to all Stroke Researchers dedicated to neurovascular diseases that participated in this study @carlomictusvh @Zini….

RT @WorldStrokeOrg: ESUS isn’t one disease. Join global experts at #WSC2025 as they crack the diagnostic code through thrombi histopatholog….

🧠 Great paper on BNP and timing of AFDAS diagnosis. 🔖Ref 1. 📌 374 #stroke pt w/o known #Afib, but AFDAS detected on cardiac monitoring (BIOSIGNAL & GRAZ cohorts). 📉 Inhospital AFDAS (72%):.🧪 NT-proBNP at admission predicts in-hospital AFDAS . ▪️Cutoff: 505 pg/mL → AUC 0.83

RT @CAlejandroneuro: Nuestra Red y Centro de ACV @SubRedNorte tendrá este mes en la tradicional reunión mensual un gran colega y amigo como….

RT @J_Rosales_MD: @SposatoL Extremely high AIS recurrence !.Agree with Dr Hawkes

🧠 PFO Closure in Ischemic Stroke & TIA Patients ≥60y.🔗 📌 Single-center cohort, n=239.👴 120 patients ≥60y.⏱ 3.1y mean follow-up. 🎯 Recurrent stroke rates.▪️PFO closure (≥60y): 6.1% (3/49).▪️No closure (≥60y): 25.4% (18/71).📉 aHR = 0.11 (95% CI:.

🧠 IV Thrombolysis in CADASIL: Safe & Effective?. Two retrospective cohort studies below👇. 📌 STUDY 1.🏥 609 CADASIL patients (Taiwan, Japan, Korea), 204 with IS.📊 Median age of 60y, 5 microbleeds, NIHSS 5. Small subcortical infarcts.💉 12 (5%) received IVT, 4 with low dose.

In case you missed it: 🙏 SANCTUARY SITES . ✅ Background. Infarction probability (Pi) maps highlight vulnerable brain regions post-stroke (basal ganglia), but they could also be used for identifying infarction-resistant areas. 🧠 Population. 154 patients with isolated or

Nice paper by @Dr_No_Charite @Jan_FriSch et al. from .@BerlinStroke @ChariteBerlin . ✅ Background. Troponin elevation is common post-stroke, but mechanisms remain unclear. 🧠 Population. 508 ischemic stroke patients with serial hs-cTnT in 1st 48h.– 254 with acute myocardial.

Thoughts:.- Great work! Large, real-world cohort (n=1795). - Both ischemic and hemorrhagic recurrences are qualifying events and part of the “early stroke recurrence” outcome. - No data on AF detection method (ECG vs. monitoring), so AF burden and mechanism are unclear. -.

New interesting analysis of early stroke recurrence in patients with AF:.- Qualifying events: 1795 first ischemic (91%) or hemorrhagic (8%) strokes between 20204 and 2025. - AF either known or detected within 6 months. Findings:.- High CHA2DS2-VASc score, concomitant etiologies,

RT @LHSCRI: A clinical trial led by LHSCRI and Western University’s @SchulichMedDent has helped improve the detection of hidden blood clots….

SURPRISE.Open access to the paper until July 8, 2025: Thanks to the great @WesternU @westernuCNS @SchulichMedDent @LHSCCanada Team @RodrigoBagur @DianaAyan77 @friseb @SACHINKISHORE82 @DebickiDerek @casserly_dr .8/8

CONCLUSIONS.1⃣ A non-gated, single-phase, extended CTA can increase the detection of cardioaortic.thrombi by 6-fold with an NNS of 14.2⃣ It only causes a minimal excess of radiation, does not require additional contrast, and does not delay acute treatment. 3⃣ Its impact on stroke.

LIMITATIONS.🛑Some thrombi were not confirmed with dedicated cardiac imaging. 🟢Pre-specified criteria were used to account for this expected limitation. 🛑70% of patients with a thrombus had #AtrialFibrillation. 🟢Stroke physicians believe finding a thrombus is still clinically

SAFETY OUTCOMES.⌛️No differences in time to completion of CTA, door-to-needle time, or door-to-groin puncture time. ☢️Slightly increased radiation exposure with extended CTA use: median of 1 mSv, equivalent to 2.5 mammograms. 5/8

EFFICACY OUTCOMES.Cardioaortic thrombi detection (primary efficacy endpoint) was 6-fold higher by applying an extended CTA compared to standard of care CTA:.🎯8.8% in the extended CT angiography group vs. 1.7% in the standard CT angiography group. 🎯OR 5.70, 95% CI 1.92–16.96;